ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma.

BioMed Research International
TingAn WangXiaoLing Luo

Abstract

Armadillo gene subfamily members (ARMCX1-6) are well-known to regulate protein-protein interaction involved in nuclear transport, cellular connection, and transcription activation. Moreover, ARMCX signals on cell pathways also implicated in carcinogenesis and tumor progression. However, little is known about the associations of the ARMCX subfamily members with gastric carcinoma. This study investigated the prognostic value of ARMCX subfamily mRNA expression levels with the prognosis of gastric carcinoma (GC). We retrieved the data of a total of 351 GC patients from TCGA database. Survival and gene set enrichment analyses were employed to explore the predictive value and underlying mechanism of ARMCX genes in GC. The multivariate survival analysis revealed that individually low expressions of ARMCX1 (adjusted P = 0.006, HR = 0.620, CI = 0.440 - 0.874) and ARMCX2 (adjusted P = 0.005, HR = 0.610, 95%CI = 0.432-0.861) were related to preferable overall survival (OS). The joint-effects analysis shown that combinations of low level expression of ARMCX1 and ARMCX2 were correlated with favorable OS (adjusted P = 0.003, HR = 0.563, 95%CI = 0.384-0.825). ARMCX1 and ARMCX2 were implicated in WNT and NF-kappaB pathways, and biological proc...Continue Reading

References

Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·S MunemitsuP Polakis
Apr 28, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K H Goss, J Groden
Feb 13, 2001·Biochemical and Biophysical Research Communications·I V KurochkinH Nomura
Aug 9, 2001·Journal of Molecular Biology·M A AndradeP Bork
Jan 25, 2005·Journal of Molecular Biology·Hee-Jung Choi, William I Weis
Mar 11, 2005·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Craig A SmithAndrew H Sinclair
Apr 15, 2005·Nature·Tannishtha Reya, Hans Clevers
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Dec 27, 2005·Current Opinion in Genetics & Development·Felix H BrembeckWalter Birchmeier
May 23, 2007·Molecular Medicine·Christopher J EdwardsDebra D Pittman
Jul 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Masuko Katoh, Masaru Katoh
Sep 21, 2007·Journal of Cell Science·Wenqing Xu, David Kimelman
Jul 22, 2009·Developmental Cell·Bryan T MacDonaldXi He
Aug 14, 2009·Current Opinion in Cell Biology·Amanda E Bass-ZubekKathleen J Green
Feb 4, 2010·PloS One·Harald StrieglUdo Heinemann
Apr 14, 2011·Expert Opinion on Therapeutic Targets·Hisayuki YaoTaira Maekawa
Nov 26, 2011·Gynecologic Oncology·Céline MontavonPhilippa M O'Brien
Apr 13, 2012·Cancer Science·Hiroyoshi IsekiIsamu Koyama
May 10, 2012·Nature Communications·Guillermo López-DoménechEduardo Soriano
Apr 8, 2015·The Lancet Oncology·Vinod P BalachandranRonald P DeMatteo
Oct 21, 2015·Biopreservation and Biobanking·Latarsha J CarithersUNKNOWN GTEx Consortium
Jan 16, 2016·Cell Systems·Arthur LiberzonPablo Tamayo
May 10, 2016·Lancet·Eric Van CutsemHans Prenen

❮ Previous
Next ❯

Software Mentioned

GraphPad Prism
GeneMANIA
GEPIA
Gene Profiling Interactive Analysis ( GEPIA
GSEA
SPSS
KOBAS

Related Concepts

Related Feeds

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis